Daiwa Securities Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Daiwa Securities Group’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-191	Closed	-$2K	–	1444
2025 Q4	$2K	Hold	191	–	–	﹤0.01%	1328
2025 Q3	$1K	Hold	191	–	–	﹤0.01%	1323
2025 Q2	$1K	Hold	191	–	–	﹤0.01%	1288
2025 Q1	$1K	Hold	191	–	–	﹤0.01%	1261
2024 Q4	$1K	Hold	191	–	–	﹤0.01%	1272
2024 Q3	$1K	Hold	191	–	–	﹤0.01%	1261
2024 Q2	$1K	Hold	191	–	–	﹤0.01%	1303
2024 Q1	$1K	Hold	191	–	–	﹤0.01%	1308
2023 Q4	$1K	Hold	191	–	–	﹤0.01%	1311
2023 Q3	$1K	Hold	191	–	–	﹤0.01%	1280
2023 Q2	$1K	Hold	191	–	–	﹤0.01%	1303
2023 Q1	$1K	Hold	191	–	–	﹤0.01%	1285
2022 Q4	$1K	Hold	191	–	–	﹤0.01%	1294
2022 Q3	$2K	Hold	191	–	–	﹤0.01%	1251
2022 Q2	$2K	Hold	191	–	–	﹤0.01%	1259
2022 Q1	$2K	Hold	191	–	–	﹤0.01%	1273
2021 Q4	$3K	Hold	191	–	–	﹤0.01%	1260
2021 Q3	$3K	Buy	191 +71	+59%	+$1.24K	﹤0.01%	1231
2021 Q2	$3K	Hold	120	–	–	﹤0.01%	1122
2021 Q1	$2K	Hold	120	–	–	﹤0.01%	1165
2020 Q4	$2K	Sell	120 -181	-60%	-$2.18K	﹤0.01%	1142
2020 Q3	$3K	Hold	301	–	–	﹤0.01%	1120
2020 Q2	$3K	Hold	301	–	–	﹤0.01%	1144
2020 Q1	$3K	Hold	301	–	–	﹤0.01%	1143
2019 Q4	$5K	Sell	301 -34	-10%	-$514	﹤0.01%	1108
2019 Q3	$4K	Hold	335	–	–	﹤0.01%	1094
2019 Q2	$5K	Hold	335	–	–	﹤0.01%	1106
2019 Q1	$6K	Buy	335 +87	+35%	+$1.98K	﹤0.01%	1072
2018 Q4	$6K	Hold	248	–	–	﹤0.01%	1045
2018 Q3	$6K	Hold	248	–	–	﹤0.01%	1076
2018 Q2	$5K	Hold	248	–	–	﹤0.01%	1098
2018 Q1	$4K	Buy	+248	New	+$4.15K	﹤0.01%	1092

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Daiwa Securities Group's VNDA Position: Q1 2026 in Review

Daiwa Securities Group sold out of Vanda Pharmaceuticals (VNDA) in Q1 2026, closing a stake of 191 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in VNDA in Q1 2018 and held it in 32 quarters. The position peaked at $6K in Q1 2019. 171 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

Daiwa Securities Group reported no remaining Vanda Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 191 Vanda Pharmaceuticals shares in Q1 2026, an estimated $2K.
Daiwa Securities Group first reported a position in Vanda Pharmaceuticals in Q1 2018 and held it in 32 quarters.
Daiwa Securities Group's Vanda Pharmaceuticals position peaked at $6K in Q1 2019.
171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.